Elihu H. Estey

65.2k citations
700 papers · 41.7k · 9 hit papers · h-index 103

Impact in

  • Hematology top 0.01%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.02%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 481
    • Chronic Myeloid Leukemia Treatments 102
    • Hematopoietic Stem Cell Transplantation 70
    • Retinoids in leukemia and cellular processes 74

Elihu H. Estey

684 papers receiving 40.4k citations

Elihu H. Estey's Hit Papers

Acute myeloid leukemia: 2019 update on risk‐stratification and management 2018 · 265 citations
2650+9+19Years since publication50010001.5k2.0k

Peers

Elihu H. Estey
Comparison fields: 5 of 168
  • Hematology 26.6k
  • Genetics 7.6k
  • Oncology 7.3k
  • Public Health, Environmental and Occupational Health 7.3k
  • Molecular Biology 14.9k
Replace Bob Löwenberg with:
Bob Löwenberg Netherlands
Martin S. Tallman United States
Guillermo Garcia‐Manero United States
Clara D. Bloomfield United States
Farhad Ravandi United States
Alan K. Burnett United Kingdom
Emil J. Freireich United States
Stefan Faderl United States
Michael Andreeff United States
Francis J. Giles United States
Elihu H. Estey relative to Bob Löwenberg Netherlands Bob Löwenberg's profile →
Citations per field
00.5×1.5×
Bob Löwenberg · 1×
Citations per year

Countries citing papers authored by Elihu H. Estey

Since Specialization
Citations

This map shows the geographic impact of Elihu H. Estey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elihu H. Estey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elihu H. Estey more than expected).

Fields of papers citing papers by Elihu H. Estey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elihu H. Estey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elihu H. Estey. The network helps show where Elihu H. Estey may publish in the future.

Co-authors

The 25 scholars most cited alongside Elihu H. Estey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elihu H. Estey Line = papers co-authored together Elihu H. Estey links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 700 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hit paper breakdown →
20092443
2
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
Hit paper breakdown →
20031926
3
Acute myeloid leukaemia
Hit paper breakdown →
20061018
4
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
Hit paper breakdown →
1997942
5
Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
Hit paper breakdown →
2001707
6
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Hit paper breakdown →
2008656
7
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
Hit paper breakdown →
2000581
8
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
Hit paper breakdown →
2014507
9 2006478
10 2010421
11 2003416
12 2008414
13 2006404
14 2005373
15 1998354
16 2005347
17 2007314
18 1999284
19 2011284
20 1999281

About Elihu H. Estey

Elihu H. Estey is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Oncology, having authored 700 papers that have together received 41.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (481 papers), Acute Lymphoblastic Leukemia research (144 papers), Chronic Myeloid Leukemia Treatments (102 papers), Retinoids in leukemia and cellular processes (74 papers), Hematopoietic Stem Cell Transplantation (70 papers), Chronic Lymphocytic Leukemia Research (67 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (61 papers) and Neutropenia and Cancer Infections (58 papers). The work is most often cited by research in Hematology (26.6k citations), Genetics (7.6k citations), Oncology (7.3k citations), Public Health, Environmental and Occupational Health (7.3k citations) and Molecular Biology (14.9k citations). Elihu H. Estey has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Hagop M. Kantarjian, Michael J. Keating, Hartmut Döhner, Jörge E. Cortes, Frederick R. Appelbaum, Susan O’Brien, Sherry Pierce, Francis J. Giles, Maher Albitar and Emil J. Freireich. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, Leukemia and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact